Medical and Pharmaceutical South Korea’s Yuhan has 690% profit spike on U.S. lung cancer drug sales Lazertinib, developed in partnership with Janssen Biotech, received FDA approval in August Rowan DunneOctober 28, 2024
Medical and Pharmaceutical New program aims to improve Florida’s lung cancer screening rate exponentially It is being implemented before Lung Cancer Awareness Month in November Rowan DunneOctober 24, 2024
Medical and Pharmaceutical Bright Minds Bio soars on US$35M private placement; up 5,400% in 5 days Developing drugs for the treatment of epilepsy, depression, obesity and other conditions is the company's forte Rowan DunneOctober 18, 2024
Medical and Pharmaceutical Can taking Aspirin reduce your risk of getting lung cancer? Some studies have indicated that it can, along with other cancers Rowan DunneOctober 17, 2024
Medical and Pharmaceutical Fertility solutions provider Progyny tanks after losing top client Progyny's termination by the unnamed client in January will result in a 13% loss of revenue, approximately Rowan DunneSeptember 19, 2024
Psychedelics California startup Tactogen gets U.S. patent for MDMA derivatives The company focuses on developing novel psychoactive drugs with more gentle effects Rowan DunneSeptember 27, 2023
Health & Wellness GSK acquires late-stage Canadian biopharma company BELLUS Health for USD$2B Approximately 28 million patients suffer from refractory chronic cough Joseph MortonApril 20, 2023
Cannabis Cybin receives Schedule I DEA license for CYB003 trial New license is the final required step before administering doses to study participants Rowan DunneAugust 17, 2022
Business Tetra Bio-Pharma partners with Avicanna to bring cannabinoid medical products to LATAM Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) is teaming up with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to bring Tetra’s products... Natalia Buendia CalvilloFebruary 14, 2022
The weed wire One of Europe’s largest pharma firms inks supply deal with MediPharm The Canadian extractor says Germany-based Stada will forge the path ahead for big pharma to commercialize medical cannabis Jared GnamOctober 5, 2020